Education
About Us
Working with TipRanks
Follow Us
Ascendis Pharma (ASND)
NASDAQ:ASND
ASND Analyst Ratings
Strong Buy
13 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ASND Stock 12 Month Forecast
Average Price Target
$221.85
▲(27.21%Upside)
| Highest Price Target$289.00 | Average Price Target$221.85 | Lowest Price Target$194.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bank of America Securities
$196→$201
Buy
15.25%
Upside
Reiterated
06/02/25
Stifel Nicolaus
$212
Buy
21.56%
Upside
Reiterated
05/27/25
Morgan Stanley
$250
Buy
43.35%
Upside
Reiterated
05/27/25
Wells Fargo
$289
Buy
65.71%
Upside
Reiterated
05/21/25
Cantor Fitzgerald
$280→$200
Buy
14.68%
Upside
Reiterated
05/12/25
TD Cowen
$162→$194
Buy
11.24%
Upside
Reiterated
05/02/25
J.P. Morgan
$200→$245
Buy
40.48%
Upside
Reiterated
05/02/25
Oppenheimer
$180→$215
Buy
23.28%
Upside
Reiterated
05/02/25
Leerink Partners
$190→$200
Buy
14.68%
Upside
Reiterated
05/01/25
Wedbush
$181→$212
Buy
21.56%
Upside
Reiterated
05/01/25
RBC Capital
$205→$210
Buy
20.41%
Upside
Reiterated
05/01/25
Evercore ISI
$260
Buy
49.08%
Upside
Reiterated
04/25/25
UBS
$196
Buy
12.39%
Upside
Reiterated
03/27/25
Goldman Sachs
$200→$225
Buy
29.01%
Upside
Reiterated
02/13/25
Jefferies
$194
Buy
11.24%
Upside
Assigned
12/17/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bank of America Securities
$196→$201
Buy
15.25%
Upside
Reiterated
06/02/25
Stifel Nicolaus
$212
Buy
21.56%
Upside
Reiterated
05/27/25
Morgan Stanley
$250
Buy
43.35%
Upside
Reiterated
05/27/25
Wells Fargo
$289
Buy
65.71%
Upside
Reiterated
05/21/25
Cantor Fitzgerald
$280→$200
Buy
14.68%
Upside
Reiterated
05/12/25
TD Cowen
$162→$194
Buy
11.24%
Upside
Reiterated
05/02/25
J.P. Morgan
$200→$245
Buy
40.48%
Upside
Reiterated
05/02/25
Oppenheimer
$180→$215
Buy
23.28%
Upside
Reiterated
05/02/25
Leerink Partners
$190→$200
Buy
14.68%
Upside
Reiterated
05/01/25
Wedbush
$181→$212
Buy
21.56%
Upside
Reiterated
05/01/25
RBC Capital
$205→$210
Buy
20.41%
Upside
Reiterated
05/01/25
Evercore ISI
$260
Buy
49.08%
Upside
Reiterated
04/25/25
UBS
$196
Buy
12.39%
Upside
Reiterated
03/27/25
Goldman Sachs
$200→$225
Buy
29.01%
Upside
Reiterated
02/13/25
Jefferies
$194
Buy
11.24%
Upside
Assigned
12/17/24
Best Analysts Covering Ascendis Pharma
1 Month
xxx
Success Rate
11/15 ratings generated profit
Average Return
+6.66%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 73.33% of your transactions generating a profit, with an average return of +6.66% per trade.
3 Months
xxx
Success Rate
19/25 ratings generated profit
Average Return
+11.94%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 76.00% of your transactions generating a profit, with an average return of +11.94% per trade.
1 Year
Success Rate
24/29 ratings generated profit
Average Return
+23.02%
reiterated a buy rating 3 days ago
Copying Tazeen Ahmad's trades and holding each position for 1 Year would result in 82.76% of your transactions generating a profit, with an average return of +23.02% per trade.
2 Years
xxx
Success Rate
15/15 ratings generated profit
Average Return
+50.46%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +50.46% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ASND Analyst Recommendation Trends
Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
11
10
9
7
6
Buy
23
25
22
23
16
Hold
15
14
11
7
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
49
49
42
37
25
Each month's total comprises the sum of three months' worth of ratings.
ASND Financial Forecast
ASND Stock Forecast FAQ
What is ASND’s average 12-month price target, according to analysts?
Based on analyst ratings, Ascendis Pharma’s 12-month average price target is 221.85.
What is ASND’s upside potential, based on the analysts’ average price target?
Ascendis Pharma has 27.21% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ASND a Buy, Sell or Hold?
Ascendis Pharma has a consensus rating of Strong Buy which is based on 13 buy ratings, 0 hold ratings and 0 sell ratings.
What is Ascendis Pharma’s price target?
The average price target for Ascendis Pharma is 221.85. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $289.00 ,the lowest forecast is $194.00. The average price target represents 27.21% Increase from the current price of $174.4.
The highest analyst price target is $289.00 ,the lowest forecast is $194.00. The average price target represents 27.21% Increase from the current price of $174.4.
What do analysts say about Ascendis Pharma?
Ascendis Pharma’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of ASND?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.